Results 26 patients had been followed up for 1-5 years, and no case recurred.
结果26例病人均得到1 ~5年的随访，无1例病人出现肿瘤复发。
All patients were followed up for more than 3 months, no single case recurred.
全部患者均随访3个月以上，且无一例复发。
Results in all 20 patients, 19 cases were cured, the cure rate was 95%. One case recurred. No pigment and scar were found in focus.
结果20例治愈19例，治愈率95%，除1例其余患者原发病无复发，局部无瘢痕及色素沉着。
Results 64 cases was resected completely, 58 cases was functionally cured, 3 cases got better, 3 cases got better obviously. no death occurred. 1 case recurred.
结果64例患者肿瘤全切，神经功能完全改善58例，显著改善3例，明显改善3例，无恶化和死亡患者，复发1例。
If that was the case, it is possible that cancer has recurred; the anti-rejection drugs can increase the odds of cancer recurrence.
如果是这样的话，很有可能癌症又复发了。抗排异的药物会增加癌症复发的可能性。
Results Patients were followed up 6 ~ 33 months after operation, no infection case was recurred, C-reaction protein and blood sedimentation were normal, joint function was good.
结果术后随访6 ~33个月，无一例感染复发；复查c反应蛋白、血沉，皆恢复正常；关节功能恢复满意。
Results Patients were followed up 6 ~ 33 months after operation, no infection case was recurred, C-reaction protein and blood sedimentation were normal, joint function was good.
结果术后随访6 ~33个月，无一例感染复发；复查c反应蛋白、血沉，皆恢复正常；关节功能恢复满意。
应用推荐